CLARIENT, INC. AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • April 19th, 2010 • Clarient, Inc • Services-medical laboratories
THIS AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER (the “Amendment”) is dated as of April 14, 2010, by and among Clarient, Inc., a Delaware corporation (“Parent”), Applied Genomics, Inc., a Delaware corporation (the “Company”), and Robert S. Seitz, an individual resident of the State of Alabama (the “Stockholders’ Representative”), as representative of the stockholders of the Company (the “Stockholders”) pursuant to Section 7.1(a) of the Merger Agreement (as defined below). The Amendment shall be effective as of March 17, 2010. All capitalized terms not herein defined shall have the definitions ascribed to them in the Merger Agreement.
